Silvergate Pharmaceuticals Merges With CutisPharma To Serve Patients On Opposite Ends of the Spectrum
By: Colorado BioScience Association Date: 07/10/2019
Silvergate Pharmaceuticals produces pediatric medications, while CutisPharma has served the senior population. They’re bringing their companies together to form Azurity Pharmaceuticals.
While it might initially seem like the two patient groups have little in common, Azurity’s CEO Neal Muni believes joining forces was a very natural move. Both populations often require specialized dosing and may struggle with swallowing pills.
“It made a lot of sense strategically to better serve our patients,” Muni said. “We started talking with Silvergate and their investors quite some time back about the potential opportunity to combine the two companies. With this combination of the two we can reaffirm our commitment to the same patient populations with much larger capability.”